Literature DB >> 11714098

Rescue of the Friedreich's ataxia knockout mouse by human YAC transgenesis.

M A Pook1, S Al-Mahdawi, C J Carroll, M Cossée, H Puccio, L Lawrence, P Clark, M B Lowrie, J L Bradley, J M Cooper, M Koenig, S Chamberlain.   

Abstract

We have generated and characterised transgenic mice that contain the entire Friedreich's ataxia gene (FRDA) within a human YAC clone of 370 kb. In an effort to overcome the embryonic lethality of homozygous Frda knockout mice and to study the behaviour of human frataxin in a mouse cellular environment, we bred the FRDA YAC transgene onto the null mouse background. Phenotypically normal offspring that express only YAC-derived human frataxin were identified. The human frataxin was expressed in the appropriate tissues at levels comparable to the endogenous mouse frataxin, and it was correctly processed and localised to mitochondria. Biochemical analysis of heart tissue demonstrated preservation of mitochondrial respiratory chain function, together with some increase in citrate synthase and aconitase activities. Thus, we have demonstrated that human frataxin can effectively substitute for endogenous murine frataxin in the null mutant. Our studies are of immediate consequence for the generation of Friedreich's ataxia transgenic mouse models, and further contribute to the accumulating knowledge of human-mouse functional gene replacement systems.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714098     DOI: 10.1007/s100480100118

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  30 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

2.  The mismatch repair system protects against intergenerational GAA repeat instability in a Friedreich ataxia mouse model.

Authors:  Vahid Ezzatizadeh; Ricardo Mouro Pinto; Chiranjeevi Sandi; Madhavi Sandi; Sahar Al-Mahdawi; Hein Te Riele; Mark A Pook
Journal:  Neurobiol Dis       Date:  2012-01-20       Impact factor: 5.996

3.  Evaluation of an FRDA-EGFP genomic reporter assay in transgenic mice.

Authors:  Joseph P Sarsero; Timothy P Holloway; Lingli Li; Samuel McLenachan; Kerry J Fowler; Ivan Bertoncello; Lucille Voullaire; Sophie Gazeas; Panos A Ioannou
Journal:  Mamm Genome       Date:  2005-04       Impact factor: 2.957

4.  Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia.

Authors:  Françoise Piguet; Charline de Montigny; Nadège Vaucamps; Laurence Reutenauer; Aurélie Eisenmann; Hélène Puccio
Journal:  Mol Ther       Date:  2018-05-28       Impact factor: 11.454

5.  Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.

Authors:  R Mark Payne; P Melanie Pride; Clifford M Babbey
Journal:  Pediatr Cardiol       Date:  2011-03-01       Impact factor: 1.655

6.  PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia.

Authors:  Daniele Marmolino; Mario Manto; Fabio Acquaviva; Paola Vergara; Ajay Ravella; Antonella Monticelli; Massimo Pandolfo
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

7.  Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.

Authors:  Sara Pérez-Luz; Javier Díaz-Nido
Journal:  J Biomed Biotechnol       Date:  2010-08-24

Review 8.  Multicellular models of Friedreich ataxia.

Authors:  Hélène Puccio
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

9.  Autologous stem cell transplant with gene therapy for Friedreich ataxia.

Authors:  Naoki Tajiri; Meaghan Staples; Yuji Kaneko; Seung U Kim; Theresa A Zesiewicz; Cesar V Borlongan
Journal:  Med Hypotheses       Date:  2014-06-09       Impact factor: 1.538

10.  The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia.

Authors:  Nadège Calmels; Stéphane Schmucker; Marie Wattenhofer-Donzé; Alain Martelli; Nadège Vaucamps; Laurence Reutenauer; Nadia Messaddeq; Cécile Bouton; Michel Koenig; Hélène Puccio
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.